Cancer Institute And Hospital, Chinese Academy Of Medical Sciences
Clinical trials sponsored by Cancer Institute And Hospital, Chinese Academy Of Medical Sciences, explained in plain language.
-
New combo attack on rectal cancer shows promise in reducing recurrence
Disease control CompletedThis study looked at 180 adults with rectal cancer that had spread to nearby lymph nodes. It compared a strong three-drug chemo regimen (FOLFOXIRI) plus surgery to remove affected lymph nodes against standard chemo and radiation before surgery. The goal was to see if the new appr…
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 26, 2026 07:10 UTC
-
Experimental cell injection targets Hard-to-Treat brain lining tumors
Disease control CompletedThis early study tested a new treatment called QH104 for people with solid tumors that have spread to the lining of the brain (meningeal metastases). The treatment uses specially engineered immune cells (B7H3 CAR-γδ T cells) injected directly into the fluid around the brain. Only…
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 26, 2026 07:07 UTC
-
New combo therapy aims to improve sarcoma surgery outcomes
Disease control CompletedThis study tested giving a targeted drug (apatinib) along with radiation therapy before surgery for soft tissue sarcoma in the arms, legs, or trunk. The goal was to see if this combination is safe and helps control the disease. 30 adults took part in this phase 2 trial.
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 26, 2026 06:51 UTC